Recruiting Sarcoma Studies in Philadelphia
Lurbinectedin in FET-Fused Tumors
The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma....
Trial of Ixazomib for Kaposi Sarcoma
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth....
About Sarcoma Clinical Trials in Philadelphia
Sarcomas are rare cancers that arise in bone and soft tissues including muscle, fat, blood vessels, and connective tissue. There are more than 70 subtypes of sarcoma. Treatment usually involves surgery combined with radiation and/or chemotherapy.
There are currently 2 sarcoma clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 104 participants. Research is being sponsored by Children's Hospital of Philadelphia, AIDS Malignancy Consortium. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sarcoma Clinical Trials in Philadelphia — FAQ
Are there sarcoma clinical trials in Philadelphia?
Yes, there are 2 sarcoma clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What sarcoma treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma.
Data updated March 2, 2026 from ClinicalTrials.gov